Elevating Clinical Excellence: TLCx Appoints Dr Ries as Chief Medical Officer
"This is more than just a clinical appointment; it signifies a key milestone in realizing TLCx's Vision 2030," said Dr.
TLCx is pleased to welcome Dr.
Dr.
The addition of a Chief Medical Officer will benefit the company in the following ways:
Enhanced Clinical Leadership: Dr. Ries will provide vital leadership, ensuring TLCx's strategies and innovations are firmly rooted in medical expertise.
Patient-Centered Approach: With
Realization of Vision 2030: This appointment marks a milestone in realizing TLCx's Vision 2030, moving the company closer to its goal of transforming healthcare patient experience.
Drive Innovation: Dr. Ries will also help drive innovation at TLCx, leading development of products, services, and solutions that improve patient experience and outcomes.
About TLCx:
TLCx is a certified veteran-owned company dedicated to enhancing customer experiences for Fortune 500 companies through innovative outsourcing solutions. With a focus on operational excellence and a people-first culture, TLCx has been a trusted partner in the CX industry for 18 years.
For more information, visit www.tlcx.com.
Media Contact:
Chief Commercial Officer
215-385-4425
[email protected]
TLCx
www.tlcx.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/elevating-clinical-excellence-tlcx-appoints-dr-ries-as-chief-medical-officer-302529236.html
SOURCE TLCx
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Second Lady Usha Vance Joins Governors, National Education Leaders at Reagan Institute's Education Summit
- NEW ERA UNVEILS HEADWEAR AND APPAREL COLLABORATION WITH TEAM FIFTY5, BY CARLOS SAINZ
- IdentityIQ Expands Access to Identity Protection and Financial Wellness Tools with New Spanish-Language Experience
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share